BATS BZX Real-Time Price
As of 11:01am ET
| -0.65 / -1.09%|
The 9 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 57.00, with a high estimate of 90.00 and a low estimate of 47.00. The median estimate represents a -2.95% decrease from the last price of 58.73.
The current consensus among 10 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.